Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study - Concepedia

Concepedia

Publication | Open Access

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

DOI Full Paper Access

59

Citations

29

References

2022

Year

María Chaparro, Iria Bastón‐Rey, E Fernández-Salgado, Javier González García, Laura Ramos, M T Diz-Lois Palomares, Federico Argüelles‐Arias, Eva Iglesias Flores, Mercedes Cabello, Saioa Rubio Iturria,

Inflammatory Bowel Diseases

Abstract

Ustekinumab is effective and safe as short- and long-term treatment in a refractory cohort of CD patients in real-world clinical practice.

References

	Year	Citations

Page 1